NeuroD1 is frequently expressed in Merkel cell polyomavirus-negative and keratin 20-negative Merkel cell carcinoma: A potential diagnostic pitfall
American Journal of Clinical Pathology · 2025
DOI: 10.1093/ajcp/aqaf046 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Paweł Karpiński und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Wroclaw Medical University, Wroclaw, Poland. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Basic Helix-Loop-Helix Proteins, Biomarkers, Tumor, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
Neurogenic differentiation factor 1 (NeuroD1) is a known marker of a subtype of small cell lung carcinoma (SCLC). In this study, we aim to assess whether there is an association between NeuroD1 with Merkel cell polyomavirus (MCPyV) status, keratin 20, thyroid transcription factor 1 (TTF1), and overall survival (OS) in 125 Merkel cell carcinomas (MCCs).
Methods
NeuroD1-positive MCC tumors were characterized by immunohistochemical stains and an external RNA sequencing data set.
Results
NeuroD1 positivity (10%-100%) was seen in 29 (23%) of 125 cases, with 60 (48%) of 126 and 113 (94%) of 120 tumors MCPyV positive and keratin 20 positive, respectively. Focal TTF1 expression was seen in 9 (7.5%) of 120 tumors. NeuroD1 expression was seen more frequently in MCPyV-negative than MCPyV-positive MCCs (P = .0002) and more frequently in keratin 20–negative tumors vs keratin 20–positive ones (P < .0001). Increased NEUROD1 expression in MCPyV-negative MCC (P < .005) was confirmed in an external RNA sequencing data set (GSE235092). Univariate analyses showed NeuroD1 positivity and MCPyV-negative status correlated with worse OS (P = .024 and P = .0076, respectively); however, only MCPyV status remained significant in multivariate analyses (P = .033).
Conclusions
NeuroD1-positive MCCs are significantly correlated with MCPyV-negative, keratin 20–negative expression, and focal TTF1 expression. NeuroD1 expression can pose a potential diagnostic pitfall in the distinction of MCC from SCLC, especially in a setting of a limited immunohistochemical panel.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Wroclaw Medical University, Wroclaw, Poland.
- Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
ORCID-Profile: Mai P Hoang
Zitieren
APA
Karpiński, P., Wu, C. L., & Hoang, M. P. (2025). NeuroD1 is frequently expressed in Merkel cell polyomavirus-negative and keratin 20-negative Merkel cell carcinoma: A potential diagnostic pitfall. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf046
Vancouver
Karpiński P, Wu CL, Hoang MP. NeuroD1 is frequently expressed in Merkel cell polyomavirus-negative and keratin 20-negative Merkel cell carcinoma: A potential diagnostic pitfall. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf046
BibTeX
@article{Karpiski2025,
author = {Karpiński, Paweł and Wu, Cheng-Lin and Hoang, Mai P},
title = {NeuroD1 is frequently expressed in Merkel cell polyomavirus-negative and keratin 20-negative Merkel cell carcinoma: A potential diagnostic pitfall},
journal = {American Journal of Clinical Pathology},
year = {2025},
doi = {10.1093/ajcp/aqaf046}
}
EUVIMED